Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Dansereau, J; Joshi, AK; Helewa, ME; Doran, TA; Lange, IR; Luther, ER; Farine, D; Schulz, ML; Horbay, GLA; Griffin, P; Wassenaar, W
   Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section
   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
   
   J. Dansereau et al., "Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section", AM J OBST G, 180(3), 1999, pp. 670-676
2. DANSEREAU J; JOSHI AK; HELEWA ME; DORAN TA; LANGE IR; LUTHER ER; FARINE D; SCHULZ ML; HORBAY GLA; GRIFFIN P; WASSENAAR W
   DOUBLE-BLIND COMPARISON OF CARBETOCIN VERSUS OXYTOCIN IN PREVENTING UTERINE ATONY POST CESAREAN-SECTION
   European journal of obstetrics, gynecology, and reproductive biology
   
   J. Dansereau et al., "DOUBLE-BLIND COMPARISON OF CARBETOCIN VERSUS OXYTOCIN IN PREVENTING UTERINE ATONY POST CESAREAN-SECTION", European journal of obstetrics, gynecology, and reproductive biology, 69(1), 1996, pp. 37-37
3. GAMBLING DR; DANSEREAU J; WASSENAAR W; SCHULZ M; HORBAY GLA
   DOUBLE-BLIND - RANDOMIZED COMPARISON OF A SINGLE-DOSE OF CARBETOCIN VS 8 HOURS OXYTOCIN INFUSION AFTER CESAREAN DELIVERY - SAFETY DATA
   Anesthesia and analgesia
   
   D.R. Gambling et al., "DOUBLE-BLIND - RANDOMIZED COMPARISON OF A SINGLE-DOSE OF CARBETOCIN VS 8 HOURS OXYTOCIN INFUSION AFTER CESAREAN DELIVERY - SAFETY DATA", Anesthesia and analgesia, 78(2), 1994, pp. 77-77
4. SILCOX J; SCHULZ P; HORBAY GLA; WASSENAAR W
   TRANSFER OF CARBETOCIN INTO HUMAN BREAST-MILK
   Obstetrics and gynecology
   
   J. Silcox et al., "TRANSFER OF CARBETOCIN INTO HUMAN BREAST-MILK", Obstetrics and gynecology, 82(3), 1993, pp. 456-459